Chemours Extends $1.05 Billion Loan Maturity

Chemours Company ( (CC) ) has provided an announcement.

On October 15, 2025, Chemours Company amended its credit agreement to extend the maturity date of a $1.05 billion term loan facility to October 15, 2032, and adjusted the applicable margin rates. This move is likely to impact the company’s financial stability positively by providing more time for repayment and potentially reducing interest expenses. Additionally, on October 13, 2025, Chemours’ subsidiaries entered into a Receivables Purchase Agreement with BNP Paribas Factor GmbH, allowing the sale of receivables up to €180 million. This agreement could enhance liquidity for Chemours by converting receivables into immediate cash, thus supporting its operational cash flow.

The most recent analyst rating on (CC) stock is a Buy with a $19.00 price target. To see the full list of analyst forecasts on Chemours Company stock, see the CC Stock Forecast page.

Spark’s Take on CC Stock

According to Spark, TipRanks’ AI Analyst, CC is a Neutral.

The overall stock score of 41 reflects significant financial challenges, including high leverage and negative profitability, which are the most impactful factors. Technical analysis indicates bearish momentum, further weighing on the score. While the dividend yield offers some support, valuation concerns persist due to negative earnings.

To see Spark’s full report on CC stock, click here.

More about Chemours Company

The Chemours Company operates in the chemical industry, focusing on the production of performance chemicals. Its primary products include titanium technologies, fluoroproducts, and chemical solutions, serving markets such as automotive, electronics, energy, and consumer goods.

Average Trading Volume: 3,550,695

Technical Sentiment Signal: Sell

Current Market Cap: $2.16B

For an in-depth examination of CC stock, go to TipRanks’ Overview page.